Genetic variants in ATP6 and ND3 mitochondrial genes are not associated with aggressive prostate cancer in Mexican–Mestizo men with overweight or obesity

References

• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015. CA Cancer J Clin 2015;65:5–29
   PubMed Web of Science ®Google Scholar
• Ríos PR, Rivera AG, Cervantes FS, et al. Tendencia de la mortalidad por cáncer en México: 1990--2012. Evidencia Medica E Invest EnSalud 2015;8:5–15. Available from: http://www.medigraphic.com/pdfs/evidencia/eo-2015/eo151b.pdf
   Google Scholar
• Vance TM, Wang Y, Su LJ, et al. Sociodemographic, clinical, and lifestyle factors associated with prostate cancer aggressiveness in a population-based study. FASEB J 2013;27:1061–2
   Web of Science ®Google Scholar
• Nelson WG, De Marzo AM, Isaacs WB. Prostate cancer. Mechanisms of disease. N Engl J Med 2003;349:366–81
   PubMed Web of Science ®Google Scholar
• Labbé DP, Zadra G, Ebot EM, et al. Role of diet in prostate cancer: the epigenetic link. Oncogene 2015;34:4683–91
   PubMed Web of Science ®Google Scholar
• Discacciati A, Orsini N, Wolk A. Body mass index and incidence of localized and advanced prostate cancer -- a dose-response meta-analysis of prospective studies. Ann Oncol 2012;23:1665–71
   PubMed Web of Science ®Google Scholar
• Allott EH, Masko EM, Freedland SJ. Obesity and prostate cancer: weighing the evidence. Eur Urol 2013;63:800–9
   PubMed Web of Science ®Google Scholar
• Cantarutti A, Bonn SE, Adami HO, et al. Body mass index and mortality in men with prostate cancer. Prostate 2015;75:1129–36
   PubMed Web of Science ®Google Scholar
• Møller H, Roswall N, Van Hemelrijck M, et al. Prostate cancer incidence, clinical stage and survival in relation to obesity: a prospective cohort study in Denmark. Int J Cancer 2015;136:1940–7
   PubMed Web of Science ®Google Scholar
• Cao Y, Ma J. Body mass index, prostate cancer-specific mortality, and biochemical recurrence: a systematic review and meta-analysis. Cancer Prev Res (Phila) 2011;4:486–501
   PubMed Web of Science ®Google Scholar
• ENSANUT. Encuesta Nacional de Salud y Nutrición Cuernavaca. México: Instituto Nacional de Salud Pública; 2012
   Google Scholar
• Galluzzi L, Kepp O, Trojel-Hansen C, Kroemer G. Mitochondrial control of cellular life, stress, and death. Circ Res 2012;111:1198–207
   PubMed Web of Science ®Google Scholar
• Jackson AL, Loeb LA. The contribution of endogenous sources of DNA damage to the multiple mutations in cancer. Mutat Res 2001;477:7–21
   PubMed Web of Science ®Google Scholar
• Jackson AL, Chen R, Loeb LA. Induction of microsatellite instability by oxidative DNA damage. Proc Natl Acad Sci USA 1998;95:12468–73
   PubMed Web of Science ®Google Scholar
• Benhar M, Engelberg D, Levitzki A. ROS, stress activated kinases and stress signaling in cancer. EMBO Rep 2002;3:420–5
   PubMed Web of Science ®Google Scholar
• Ishikawa K, Takenaga K, Akimoto M, et al. ROS-generating mitochondrial DNA mutations can regulate tumor cell metastasis. Science 2008;320:661–4
   PubMed Web of Science ®Google Scholar
• Petros JA, Baumann AK, Ruiz-Pesini E, et al. mtDNA mutations increase tumorigenicity in prostate cancer. Proc Natl Acad Sci USA 2005;102:719–24
   PubMed Web of Science ®Google Scholar
• Gómez-Zaera M, Abril J, González L, et al. Identification of somatic and germline mitochondrial DNA sequence variants in prostate cancer patients. Mutat Res 2006;595:42–51
   PubMed Web of Science ®Google Scholar
• Kloss-Brandstätter A, Schäfer G, Erhart G, et al. Somatic mutations throughout the entire mitochondrial genome are associated with elevated PSA levels in prostate cancer patients. Am J Hum Genet 2010;87:802–12
   PubMed Web of Science ®Google Scholar
• Arnold RS, Fedewa SA, Goodman M, et al. Bone metastasis in prostate cancer: recurring mitochondrial DNA mutation reveals selective pressure exerted by the bone microenvironment. Bone 2015;78:81–6
   PubMed Web of Science ®Google Scholar
• Keaney JF Jr, Larson MG, Vasan RS, et al. Framingham Study. Obesity and systemic oxidative stress: clinical correlates of oxidative stress in the Framingham study. Arterioscler Thromb Vasc Biol 2003;23:434–9
   PubMed Web of Science ®Google Scholar
• Medina-Gómez G. Mitochondria and endocrine function of adipose tissue. Best Pract Res Clin Endocrinol Metab 2012;26:791–804
   PubMed Web of Science ®Google Scholar
• Fujikawa K, Sasaki M, Arai Y, et al. Prognostic criteria in patients with prostate cancer: Gleason score versus volume-weighted mean nuclear volume. Clin Cancer Res 1997;3:613–18
   PubMed Web of Science ®Google Scholar
• Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988;16:1215
   PubMed Web of Science ®Google Scholar
• Forster P. Ice Ages and the mitochondrial DNA chronology of human dispersals: a review. Philos Trans R Soc Lond B 2004;359:255–64
   PubMed Web of Science ®Google Scholar
• Wallace DC. Bioenergetics in human evolution and disease: implications for the origins of biological complexity and the missing genetic variation of common diseases. Philos Trans R Soc Lond B 2013;368:20120267
   PubMed Web of Science ®Google Scholar
• Lisker R, Ramirez E, Perez-Briceño R, et al. Gene frequencies and admixture estimates in four Mexican urban centers. Hum Biol 1990;62:791–801
   PubMed Web of Science ®Google Scholar
• Bekker-Mendez C, Yamamoto-Furusho JK, Vargas-Alarcón G, et al. Haplotype distribution of class II MHC genes in Mexican patients with systemic lupus erythematosus. Scand J Rheumatol 1998;27:373–6
   PubMed Web of Science ®Google Scholar
• Jonckheere AI, Smeitink JA, Rodenburg R. Mitochondrial ATP synthase: architecture, function and pathology. J Inherit Metab Dis 2012;35:211–25
   PubMed Web of Science ®Google Scholar
• Amuthan G, Biswas G, Zhang SY, et al. Mitochondria-to-nucleus stress signaling induces phenotypic changes, tumor progression and cell invasion. EMBO J 2001;20:1910–20
   PubMed Web of Science ®Google Scholar
• Matsuyama S, Xu Q, Velours J, Reed JC. The Mitochondrial F0F1-ATPase proton pump is required for function of the proapoptotic protein Bax in yeast and mammalian cells. Mol Cell 1998;1:327–36
   PubMed Web of Science ®Google Scholar
• Abril J, de Heredia ML, González L, et al. Altered expression of 12S/MT-RNR1, MT-CO2/COX2, and MT-ATP6 mitochondrial genes in prostate cancer. Prostate 2008;68:1086–96
   PubMed Web of Science ®Google Scholar
• Arnold RS, Sun CQ, Richards JC, et al. Mitochondrial DNA mutation stimulates prostate cancer growth in bone stromal environment. Prostate 2009;69:1–11
   PubMed Web of Science ®Google Scholar
• Singh RK, Srivastava A, Kalaiarasan P, et al. mtDNA germ line variation mediated ROS generates retrograde signaling and induces pro-cancerous metabolic features. Sci Rep 2014;4:6571
   PubMed Web of Science ®Google Scholar
• Jeronimo C, Nomoto S, Caballero OL, et al. Mitochondrial mutations in early stage prostate cancer and bodily fluids. Oncogene 2001;20:5195–8
   PubMed Web of Science ®Google Scholar